Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Guizhou Xinbang Pharmaceutical Co., Ltd.
  6. News
  7. Summary
    002390   CNE100000NG5

GUIZHOU XINBANG PHARMACEUTICAL CO., LTD.

(002390)
  Report
End-of-day quote Shenzhen Stock Exchange  -  2022-09-26
4.770 CNY   +5.07%
08/24Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
CI
05/18Guizhou Xinbang Pharmaceutical Co., Ltd. Announces Implementation of Final Cash Dividend for 2021, Payable on 24 May 2022
CI
05/09Guizhou Xinbang Pharmaceutical Co., Ltd. Approves Cash Dividend
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Guizhou Xinbang Pharmaceutical Co., Ltd. Approves Cash Dividend

05/09/2022 | 03:33pm EDT

Guizhou Xinbang Pharmaceutical Co., Ltd. held its Annual General Meeting of 2021 on 06 May 2022, during which it approved: Cash dividend/10 shares (tax included): CNY 0.60000000.


© S&P Capital IQ 2022
All news about GUIZHOU XINBANG PHARMACEUTICAL CO., LTD.
08/24Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year End..
CI
05/18Guizhou Xinbang Pharmaceutical Co., Ltd. Announces Implementation of Final Cash Dividen..
CI
05/09Guizhou Xinbang Pharmaceutical Co., Ltd. Approves Cash Dividend
CI
04/29Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter..
CI
04/15Guizhou Xinbang Pharmaceutical Co., Ltd. Announces Final Cash Dividend Proposal for 202..
CI
04/14Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year End..
CI
2021Guizhou Kekai Medicine Co., Ltd. announced that it expects to receive CNY 461.450506 mi..
CI
2021Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months E..
CI
2021Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year End..
CI
2021Guizhou Zhixin Enterprise Management Consulting Partnership Enterprise (Limited Partner..
CI
More news
Financials
Sales 2022 7 132 M 994 M 994 M
Net income 2022 352 M 49,1 M 49,1 M
Net Debt 2022 - - -
P/E ratio 2022 28,1x
Yield 2022 -
Capitalization 9 272 M 1 292 M 1 292 M
Capi. / Sales 2022 1,30x
Capi. / Sales 2023 1,17x
Nbr of Employees 5 796
Free-Float 50,1%
Chart GUIZHOU XINBANG PHARMACEUTICAL CO., LTD.
Duration : Period :
Guizhou Xinbang Pharmaceutical Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GUIZHOU XINBANG PHARMACEUTICAL CO., LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 4,77 CNY
Average target price 7,37 CNY
Spread / Average Target 54,5%
EPS Revisions
Managers and Directors
Ling Zhong Kong General Manager & Director
Ya Yun Xiao Chief Financial Officer & Deputy General Manager
Huai Lue An Chairman
Peng Wang Chairman-Supervisory Board
Yan An Dong Independent Director